Healt

Why Cochlear’s (ASX:COH) shares would be closely tracked today

August 19, 2022 09:13 AM AEST| By Ashish

Cochlear (ASX:COH) on Friday reported a rise in sales revenue in FY22, buoyed by driven by robust demand for acoustic implants

From FPH, RMD to COH: How are these healthcare giants faring on ASX

August 18, 2022 06:32 PM AEST| By Ritwika

Today the health care sector performed well and became one of the three best performing sectors on the ASX today.

What weighed on CSL’s (ASX:CSL) profit in FY22

August 17, 2022 09:18 AM AEST| By Ashish

CSL Ltd (ASX:CSL) on Wednesday announced a fall in profit in the financial year 2022 due to challenges posed by COVID-19 pandemic.

ResMed (ASX:RMD) lifts quarterly dividend, here’s how shares are reacting?

August 12, 2022 11:49 AM AEST| By Sonal Goyal

Shares of ResMed has dropped despite sharing positive quarterly results and increase in dividend.

CSL completes Vifor Pharma acquisition; here’s how shares are faring on ASX

August 10, 2022 12:34 PM AEST| By Ritwika

CSL Limited finally completed the Vifor Pharma acquisition on 9 August 2022.

How are CSL shares performing after finalisation of Vifor acquisition?

August 09, 2022 04:56 PM AEST| By Sonal Goyal

Shares of CSL Limited (ASX:CSL) gained almost 1% on the ASX today although no price sensitive news came from the company’s camp today.

Here’s why Mesoblast (ASX:MSB) has suspended trading today

August 08, 2022 03:59 PM AEST| By Ritwika

Mesoblast shares went under a voluntary suspension on the ASX today. Trading is expected to commence after the company releases its capital raising announcement on 10 August 2022.

CSL, COH, PNV: Take a look at R&D activities of ASX healthcare giants

August 05, 2022 01:46 PM AEST| By Aditi Sarkar

CSL, COH, TLX, NAN, and PNV are some of the major ASX-listed healthcare firms with strong investment and robust R&D activities.

Why are Mesoblast (ASX:MSB) shares in trading halt today?

August 04, 2022 12:27 PM AEST| By Ashish

Mesoblast Ltd (ASX:MSB) on Thursday said that it would be placing its shares in a trading halt

Up 14% in six months, can CSL shares maintain momentum on ASX?

August 04, 2022 12:07 PM AEST| By Sonal Goyal

Shares of CSL are in red today (4 August) following the benchmark performance.

A glimpse into National Disability Insurance Scheme (NDIS)

July 31, 2022 10:00 AM AEST| By Aditi Sarkar

NDIS provides monetary support and assistance to Australians born with or have acquired a permanent and significant disability.

Monkeypox cases rising in Australia; Will healthcare giants be impacted?

July 28, 2022 05:13 PM AEST| By Ritwika

Monkeypox is spreading across the entire world. Australia reported 44 confirmed case till now. The government has declared the situation as a 'national significance' . Lets see how it will impact the ASX healthcare sector.

CSL Limited (ASX:CSL) gains over 16% in six months, here’s why

July 25, 2022 06:43 PM AEST| By Ritwika

CSL shares closed in red today probably due to the delay in Vifor acquisition.

Nanosonics (ASX:NAN) expects FY22 revenue to touch AU$120M

July 25, 2022 12:18 PM AEST| By Sonal Goyal

Shares of Nanosonics (ASX:NAN) dropped by over 9% today despite sharing that its shipping volume has increased considerably

Why CSL Limited (ASX:CSL) shares closed strong on Thursday?

July 21, 2022 06:20 PM AEST| By Ritwika

CSL shares have closed in green today probably due to the sectoral influence. The S&P/ASX 200 Health Care sector was one of the best performing sectors on the ASX today.